Skip to main content
NewslettersWatchlist

Cresco Labs Inc(CL-CN)
CSE

Today's Change
Delayed Last Update
Day Low2.7000
Day High2.8000
Open:2.7000
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Business Wire
Cresco Labs Opens Second Sunnyside in Miami, Florida
Business Wire
Cresco Labs Announces Fourth Quarter & Full Year 2022 Results
Business Wire
Cresco Labs Continues Florida Expansion with Two New Store Openings
Business Wire
Cresco Labs Celebrates New Sunnyside Dispensary Opening in South Orlando, Florida
Business Wire
Cresco Labs Reaches 60 Nationwide Dispensaries with the Opening of Two Florida Stores
Business Wire
Cresco Labs and Columbia Care Mutually Extend Acquisition Closing Timeline
Business Wire
Columbia Care and Cresco Labs Mutually Extend Acquisition Closing Timeline
Business Wire
Cresco Labs Opens New Sunnyside Dispensary in Daytona Beach, Florida
Business Wire
Cresco Labs Expands Sunnyside in Pennsylvania with 11th New Store
Business Wire
Cresco Labs Welcomes Patients to 22nd Sunnyside Dispensary in Florida
Business Wire
Cresco Labs Announces Conference Participation for December 2022
Business Wire
Cresco Labs Announces Third Quarter 2022 Results
Business Wire
Cresco Labs & Columbia Care Announce Planned Divestiture in Three Markets to Sean “Diddy” Combs, Creating the First Minority-Owned, Vertically Integrated Multi-State Cannabis Operator
Business Wire
Cresco Labs to Report Third Quarter 2022 Financial Results on November 15, 2022
Business Wire
Cresco Labs Announces Board Director Sidney Dillard’s Resignation
Business Wire
Cresco Labs Opens Second Pensacola Florida Dispensary
Business Wire
Cresco Labs’ Bestselling Flagship Brand Cresco Launches in Florida
Business Wire
Cresco Labs Closes Sale-and-Leaseback with Aventine Property Group for Brookville, PA Facility
Business Wire
Cresco Labs Announces Three New Sunnyside Dispensaries in Florida
Business Wire
Cresco Labs Announces Second Quarter 2022 Results
Business Wire
Illinois Begins Issuing New Adult-Use Dispensary Licenses; Recipients Include Social Equity Groups Incubated by Cresco Labs’ SEED™ Initiative
Business Wire
Cresco Labs to Hold Second Quarter 2022 Earnings Conference Call on August 17, 2022
Business Wire
Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders
Business Wire
Columbia Care Obtains Final Order of the Supreme Court of British Columbia Approving Business Combination with Cresco Labs
Business Wire
Columbia Care Announces Approval of Business Combination with Cresco Labs at Special Meeting of Shareholders
Business Wire
Leading Independent Advisory Firm Glass Lewis Joins ISS in Recommending Columbia Care Shareholders Vote FOR the Transaction with Cresco Labs
Business Wire
Cresco Labs Announces Conference Participation for June 2022
Business Wire
Cresco Labs Announces First Quarter 2022 Results
Business Wire
Cresco Labs Announces the Expiration of the HSR Act Waiting Period for the Proposed Acquisition of Columbia Care
Business Wire
Cresco Labs to Report First Quarter 2022 Financial Results on May 18, 2022
Business Wire
Cresco Labs Announces Conference Participation for May 2022
BayStreet.ca
The U.S. is One Step Closer to Cannabis Legalization at the Federal Level

Profile

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and others. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.